[1]刘　琳,陈秋芳,付　荣,等.早期应用布地奈德对极早产儿支气管肺发育不良的影响[J].新乡医学院学报,2021,38(5):468-471.[doi:10.7683/xxyxyxb.2021.05.015]
　LIU Lin,CHEN Qiufang,FU Rong,et al.Effect of early application of budesonide on bronchopulmonary dysplasia in very preterm infants[J].Journal of Xinxiang Medical University,2021,38(5):468-471.[doi:10.7683/xxyxyxb.2021.05.015]
点击复制

早期应用布地奈德对极早产儿支气管肺发育不良的影响
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
38
期数:
2021年5
页码:
468-471
栏目:
临床研究
出版日期:
2021-05-05

文章信息/Info

Title:
Effect of early application of budesonide on bronchopulmonary dysplasia in very preterm infants
作者:
刘　琳; 陈秋芳; 付　荣; 樊姣姣
（濮阳市油田总医院儿科，河南　濮阳　457001）
Author(s):
LIU Lin; CHEN Qiufang; FU Rong; FAN Jiaojiao
(Department of Pediatrics,Puyang Oilfield General Hospital,Puyang 457001,Henan Province,China)
关键词:
极早产儿; 支气管肺发育不良; 布地奈德
Keywords:
very preterm infantbronchopulmonary dysplasiabudesonide
分类号:
R725.6
DOI:
10.7683/xxyxyxb.2021.05.015
文献标志码:
A
摘要:
目的　探讨早期应用布地奈德对极早产儿支气管肺发育不良（BPD）的影响。方法　选择2014年1月至2020年1月濮阳市油田总医院收治的168例极早产儿为研究对象，按照治疗方法将极早产儿分为A组（n=33）、B组（n=56）和C组（n=79）。3组极早产儿均给予呼吸支持、肺泡表面活性物质替代、营养支持、抗感染等常规治疗措施。在常规治疗措施基础上，B组极早产儿于出生第8天给予布地奈德雾化吸入 14 d，C组极早产儿于出生第4天给予布地奈德雾化吸入 14 d，A组极早产儿不给予布地奈德雾化吸入。分别于治疗前和治疗后检测3组极早产儿静脉血酸碱度（PH）、静脉血氧分压（PvO2）、静脉血二氧化碳分压（PvCO2）和静脉血氧饱和度（SvO2），记录3组极早产儿总氧疗时间、无创通气时间、有创通气时间和常压吸氧时间，并观察极早产儿BPD和不良反应发生情况。结果　治疗前3组极早产儿静脉血pH值、PvO2、PvCO2和SvO2比较差异无统计学意义（P＞0.05）。与治疗前比较，治疗后3组极早产儿pH值、PvO2、SvO2显著升高，PvCO2显著降低（P＜0.05）。治疗后，B组和C组极早产儿pH值、PvO2、SvO2显著高于A组，PvCO2显著低于A组（P＜0.05）。治疗后，C组极早产儿pH值、PvO2、SvO2显著高于B组，PvCO2显著低于B组（P＜0.05）。3组极早产儿的有创通气时间、常压吸氧时间比较差异无统计学意义（P＞0.05）。B组和C组极早产儿的总氧疗时间、无创通气时间显著短于A组（P＜0.05），C组极早产儿的总氧疗时间、无创通气时间显著短于B组（P＜0.05）。A组、B组和C组极早产儿BPD发生率分别为18.18%（6/33）、8.94%（5/56）、3.80%（3/79），B组和C组极早产儿BPD发生率显著低于A组（χ2=7.625、5.669，P＜0.05），C组极早产儿BPD发生率显著低于B组（χ2=9.164，P＜0.05）。A组、B组和C组极早产儿不良反应发生率分别为18.18%（6/33）、19.66%（11/56）、17.72%（14/79），3组极早产儿不良反应发生率比较差异无统计学意义（χ2=1.746，P＞0.05）。结论　布地奈德可以显著降低极早产儿BPD发生率，改善血气指标，缩短氧疗时间，且早期应用布地奈德的效果更显著。
Abstract:
Objective　To investigate the effect of early application of budesonide on bronchopulmonary dysplasia (BPD) in very preterm infants.Methods　　A total of 168 very preterm infants admitted to Puyang Oilfield General Hospital from January 2014 to January 2020 were selected as the research subjects.The very preterm infants were divided into group A (n=79),group B (n=56) and group C (n=33) according to the treatment methods.The very preterm infants in the three groups were given routine treatment such as respiratory support,alveolar surfactant replacement,nutritional support and anti-infection.On the basis of conventional treatment,the very preterm infants in the group B were treated with budesonide aerosol for 14 days on the 8th day after birth,while very preterm infants in the group C were treated with budesonide aerosol for 14 days on the 4th day after birth.The very preterm infants in the group A were not given budesonide aerosol.The venous blood hydrogen ion con centration (PH) value,Partial pressure of venous oxygen (PvO2),venous carbon dioxide pressure (PvCO2) and venous oxygen saturation (SvO2) of the very preterm infants in the three groups were detected before and after treatment.The total oxygen therapy time,noninvasive ventilation time,invasive ventilation time and normal pressure oxygen inhalation time were recorded.The incidence of BPD and adverse reactions of the very preterm infants were observed.Results　There was no significant difference in venous blood pH value,PvO2,PvCO2 and SvO2 among the three groups before treatment (P＞0.05).Compared with before treatment,the pH value,PvO2,SvO2 in the three groups were significantly increased,and the PvCO2 was significantly decreased (P<0.05).After treatment,the pH value,PvO2 and SvO2 of the very preterm infants in the group B and group C were significantly higher than those in the group A,and the PvCO2 in the group B and group C was significantly lower than that in the group A (P<0.05).After treatment,the pH value,PvO2 and SvO2 of the very preterm infants in the group C were significantly higher than those in the group B,and PvCO2 in the group C was significantly lower than that in the group B (P<0.05).There was no significant difference in invasive ventilation time and normal pressure oxygen inhalation time among the three groups (P＞0.05).The total oxygen therapy time and noninvasive ventilation time in the group B and group C were significantly shorter than those in the group A (P<0.05),and the total oxygen therapy time and noninvasive ventilation time in the group C were significantly shorter than those in the group B (P<0.05).The incidence of BPD in the group A,group B and group C was 18.18% (6/33),8.94% (5/56) and 3.80% (3/79),respectively.The incidence of BPD in the group B and group C was significantly lower than that in the group A (χ2=7.625,5.669;P＜0.05),and the incidence of BPD in the group C was significantly lower than that in the group B(χ2=9.164,P＜0.05).The incidence of adverse reactions in the group A,group B and group C was 18.18% (6/33),19.66% (11/56) and 17.72% (14/79),respectively.There was no significant difference in the incidence of adverse reactions among the three groups (χ2=1.746,P＞0.05).Conclusion　Budesonide can significantly reduce the incidence of BPD,improve blood gas indexes,shorten the oxygen therapy time in very premature infants,and the early application of budesonide has more significant effect.

参考文献/References:

［1］　陈风云.超早产儿预后的研究进展［J］.儿科药学杂志，2018，24（7）：51-55.
［2］　王丽敏，杜琳麟，沈朝斌.成纤维细胞生长因子10信号转导对肺发育及肺部疾病影响的研究进展［J］.中华实用儿科临床杂志，2020，35（14）：1117-1120.
［3］　张艳平，张珊，王自珍，等.极早产儿床旁动脉导管结扎围术期状态与支气管肺发育不良相关因素分析［J］.发育医学电子杂志，2019，7（1）：27-31.DOI：10.3969/j.issn.2095-5340.2019.01.007.
［4］　刘金玲，林燕芬，詹雪琴，等.特异性免疫治疗支气管哮喘的机制及对肺功能的影响［J］.中华实用儿科临床杂志，2020，35（21）：1610-1613.
［5］　杨晓燕，母得志.糖皮质激素在支气管肺发育不良防治中的应用与困惑［J］.中国实用儿科杂志，2020，35（2）：100-104.
［6］　中华医学会儿科学分会新生儿学组，中华儿科杂志编辑委员会.早产儿支气管肺发育不良临床管理专家共识［J］.中华儿科杂志，2020，58（5）：358-365.
［7］　KUMAR V H S,WANG H M,NIELSEN L.Short-term perinatal oxygen exposure may impair lung development in adult mice［J］.Biol Res,2020,53(1):51-63.
［8］　朱萍，李德亮，张伟业.枸橼酸咖啡因与氨茶碱治疗早产儿呼吸暂停疗效比较［J］.新乡医学院学报，2021，38（1）：66-69.
［9］　牛莹.糖皮质激素防治早产儿支气管肺发育不良的研究进展［J］.国际儿科学杂志，2019，46（5）：360-363.
［10］　黎江，陈铁强，吴敏，等.布地奈德雾化吸入治疗支气管肺发育不良的疗效观察［J］.医学临床研究，2020，37（5）：652-654.
［11］　陈萌萌，温晓红，黄金华，等.布地奈德联合咖啡因预防早产儿支气管肺发育不良的疗效研究［J］.中国儿童保健杂志，2019，27（10）：1124-1127.
［12］　李玉红，王军.布地奈德吸入治疗支气管肺发育不良早产儿的效果及对其血气指标和体质量的影响［J］.解放军预防医学杂志，2019，37（2）：167-169.
［13］　苏锦珍，杨玉兰，杨琳，等.布地奈德联合肺表面活性物质治疗早产儿支气管肺发育不良的临床研究［J］.国际儿科学杂志，2019，46（1）：61-65.
［14］　汪敏慧，储振宇，朱良梅，等.猪肺磷脂注射液联合吸入用布地奈德混悬液治疗早产儿重度呼吸窘迫综合征的临床效果分析［J］.中国医学前沿杂志：电子版，2020，12（6）：88-92.DOI：10.12037/YXQY.2020.06-16.
［15］　黄进洁，闫玉琴，李志光，等.布地奈德防治早产儿支气管肺发育不良的临床研究［J］.中国临床药理学杂志，2020，36（4）：390-392.

相似文献/References:

[1]张　剑.母乳强化剂应用时机对极早产儿预后的影响[J].新乡医学院学报,2019,36(1):064.[doi:10.7683/xxyxyxb.2019.01.013]
　ZHANG Jian.Effect of the opportunity of applying human milk fortifier on the prognosis of very premature infants[J].Journal of Xinxiang Medical University,2019,36(5):064.[doi:10.7683/xxyxyxb.2019.01.013]

更新日期/Last Update: 2021-05-05